Australia markets close in 5 hours 12 minutes

Replimune Group Inc (7R8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
5.45-0.30 (-5.22%)
At close: 06:44PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
0
0
0
0
Operating expenses
Research development
170,338
126,527
79,545
56,754
Selling general and administrative
58,674
50,553
38,769
23,201
Total operating expenses
226,879
174,166
115,144
77,148
Operating income or loss
-226,879
-174,166
-115,144
-77,148
Interest expense
6,278
4,160
2,223
3,060
Total other income/expenses net
23,960
4,330
-669
-662
Income before tax
-209,197
-173,996
-118,036
-80,870
Income tax expense
761
288
0
-
Income from continuing operations
-209,958
-174,284
-118,036
-80,870
Net income
-209,958
-174,284
-118,036
-80,870
Net income available to common shareholders
-209,958
-174,284
-118,036
-80,870
Basic EPS
-3.07
-2.99
-2.26
-1.75
Diluted EPS
-3.07
-2.99
-2.26
-1.75
Basic average shares
64,205
58,213
52,212
46,249
Diluted average shares
64,205
58,213
52,212
46,249